Foresight AI Stock Analysis
Want to see IL:FRSX full AI Analyst Report?
Foresight (FRSX) AI Stock Analysis
Foresight
(TASE:FRSX)
The score is low primarily because of fragile fundamentals: minimal and shrinking revenue, losses roughly 30x sales, and annual cash burn close to the entire remaining asset base, which makes further capital raises and shareholder dilution likely. Technicals reinforce the caution, with the price well below all major moving averages and negative MACD, though the deeply oversold RSI and Stochastic readings suggest the decline is extended. Valuation offers no support given negative earnings and no dividend. The partial offsets are a low debt load, improved gross margin near 67%, and a narrowing loss and burn trend, making this a speculative, high-risk situation dependent on successful commercialization or new funding.
Foresight (FRSX) vs. iShares MSCI Israel ETF (EIS)
- Market Cap
- ILS 1.69M
- Dividend Yield
- ―
- Average Volume (3M)
- 2.26M
- Price to Earnings (P/E)
- -0.1
- Beta (1Y)
- 0.26
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- Israel
- Employees
- 56
- Sector
- Consumer Cyclical
- Sector Strength
- 61
- Industry
- Auto - Parts
Foresight Business Overview & Revenue Model
Company Description
Foresight Autonomous Holdings Ltd., established in 2015 and headquartered in Ness Ziona, Israel, is a technology firm dedicated to creating, developing, and commercializing advanced sensor systems. While primarily focused on the global automotive sec...
How the Company Makes Money
Foresight primarily generates revenue by commercializing its vision and perception technologies through business-to-business arrangements with companies in the automotive and mobility supply chain (e.g., automakers, Tier-1/Tier-2 suppliers, and other...
Foresight Financial Statement Overview
Summary
Foresight is effectively pre-commercial: trailing revenue of only ~$0.39M is down ~10% year-over-year and continues a multi-year decline, while net losses of ~$11.6M equate to a net margin near -2,986%. Operating cash flow of about -$9.9M against ~$8.9M of total assets implies a very short runway and heavy dependence on external financing. Shareholders' equity has collapsed from $48.4M in 2021 to ~$7.1M, with the recent uptick likely from share issuance rather than profits, pointing to ongoing dilution risk. The offsets are real but modest: low leverage (debt-to-equity ~0.22), gross margin recovery to ~67%, and a steadily narrowing loss and burn trajectory versus 2022-2023 peaks.
Income Statement
8Very NegativeBalance Sheet
30NegativeCash Flow
10Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 387.50K | 430.82K | 436.00K | 497.00K | 550.00K | 120.00K |
| Gross Profit | 258.50K | 105.00K | 264.00K | 354.00K | 298.00K | 53.00K |
| EBITDA | -11.71M | -13.01M | -12.48M | -16.03M | -17.24M | -15.79M |
| Net Income | -11.57M | -13.10M | -11.14M | -18.41M | -21.68M | -15.04M |
Balance Sheet | ||||||
| Total Assets | 8.93M | 8.35M | 9.74M | 19.31M | 32.89M | 53.48M |
| Cash, Cash Equivalents and Short-Term Investments | 7.05M | 6.32M | 7.15M | 16.11M | 26.39M | 45.60M |
| Total Debt | 1.56M | 1.51M | 1.56M | 1.63M | 2.00M | 2.73M |
| Total Liabilities | 3.13M | 3.24M | 3.02M | 3.31M | 4.11M | 4.85M |
| Stockholders Equity | 7.11M | 6.23M | 6.07M | 15.39M | 28.33M | 48.41M |
Cash Flow | ||||||
| Free Cash Flow | -9.90M | -11.34M | -11.12M | -15.05M | -17.37M | -12.36M |
| Operating Cash Flow | -9.87M | -11.32M | -11.05M | -14.93M | -17.06M | -12.13M |
| Investing Cash Flow | -32.00K | -27.06K | 1.78M | 7.09M | 8.98M | -12.58M |
| Financing Cash Flow | 13.17M | 10.26M | 903.00K | 4.18M | 0 | 14.16M |
Foresight Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:FRSX, the sentiment is Negative. The current price of 1.70 is below the 20-day moving average (MA) of 2.00, below the 50-day MA of 2.88, and below the 200-day MA of 5.93, indicating a bearish trend. The MACD of -0.36 indicates Negative momentum. The RSI at 22.04 is Positive, neither overbought nor oversold. The STOCH value of 12.22 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:FRSX.
Foresight Risk Analysis
Foresight disclosed 42 risk factors in its most recent earnings report. Foresight reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksForesight Peers Comparison
Overall Rating
IL:RZR47Neutral
IL:FRSX39Underperform
Financial Indicators
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IL:FRSX | FORESIGHT AUTONOMOUS HOLDINGS LTD. | 1.70 | -20.60 | -92.38% | |
| IL:ROBO | RoboGroup Tek | 42.40 | -30.20 | -41.60% | |
| IL:VISN | Vision Sigma Ltd | 3843.00 | -1878.00 | -32.83% | |
| IL:JEEN | Jeen Tech Ai | 346.70 | 31.30 | 9.92% | |
| IL:UTRN | Utron Ltd. | 405.40 | -76.40 | -15.86% | |
| IL:RZR | Razor Labs Ltd. | 576.80 | 187.50 | 48.16% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 11, 2026
